Invention Grant
- Patent Title: Synthetic double-stranded oligonucleotides for specific inhibition of gene expression
- Patent Title (中): 用于特异性抑制基因表达的合成双链寡核苷酸
-
Application No.: US10193747Application Date: 2002-07-11
-
Publication No.: US08772469B2Publication Date: 2014-07-08
- Inventor: Eugen Uhlmann , Jochen Huber , Niki Gunkel , Sandra Neumann
- Applicant: Eugen Uhlmann , Jochen Huber , Niki Gunkel , Sandra Neumann
- Applicant Address: DE Frankfurt am Main
- Assignee: Sanofi-Aventis Deutschland GmbH
- Current Assignee: Sanofi-Aventis Deutschland GmbH
- Current Assignee Address: DE Frankfurt am Main
- Agency: Lathrop & Gage LLP
- Agent James H. Velema, Esq.
- Priority: DE10133858 20010712
- Main IPC: C07H21/02
- IPC: C07H21/02
Abstract:
The present invention relates to oligonucleotide derivatives which are at least partly double-stranded and which have a 2′5′-linked oligonucleotide residue on at least one 3′ end and to the use thereof for specific inhibition of gene expression.
Public/Granted literature
- US20030139585A1 Synthetic double-stranded oligonucleotides for specific inhibition of gene expression Public/Granted day:2003-07-24
Information query
